Generic drug shortages are worsening, with over 270 drugs in short supply as of early 2026. These aren't minor gaps - they're life-threatening disruptions caused by thin profits, single-source manufacturing, and global supply chain risks. Patients and providers are paying the price.
Hospital pharmacies are facing severe shortages of sterile injectable medications, disrupting surgeries, cancer treatments, and emergency care. With low profits, complex manufacturing, and global supply chain risks, the crisis shows no sign of easing.